Fabio Grassi

Company: MV BioTherapeutics

Job title: Founder

Seminars:

Microbiota Adaptation via Secretory IgA to Correct Dysbiosis 10:20 am

Join the session regarding: Learn the unique mechanism to enhance secretory IgA generation in the gut by the ATP-degrading enzyme apyrase Individual gut microbiota adaptation by enhanced secretory IgA in different pathophysiological conditions Conversion of non-responders to responders to immune checkpoint blockade by an apyrase-expressing biotherapeuticRead more

day: Track A - Afternoon - Day One